Dominus is a leading pharmaceutical company, having HQ at Bangalore, India. At Dominus Healthcare, we are having diverse products across different therapeutic segments. We have established brands marketed across the Indian market. We are continuously achieving innovations to bring the new products into the market.

Each uncoated tablet contains:

Vildagliptin ………………………………………50 mg

Metformin Hydrochloride HCl IP………………500 mg

Tablet

Vibesta-M combines two antihyperglycemic agents with different mechanisms of action to improve glycemic control in patients with type 2 diabetes: vildagliptin, a member of the DPP-4 (dipeptidyl-peptidase-4) inhibitor class and metformin hydrochloride, a member of the biguanide class.

Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycemic control. Vildagliptin inhibition of DPP-4 results in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

Metformin hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Metformin hydrochloride stimulates intracellular glycogen synthesis by acting on glycogen synthase and increase the transport capacity of specific types of membrane glucose transporters (GLUT-1 and GLUT-4).

Strip containing 10 tablets. 

Alu alu packing. 

Vibesta M brand of Vildagliptin and Metformin